YARDLEY, Pa., June 2, 2021 /PRNewswire/ — Optinose (NASDAQ:OPTN), a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy ...
A new study undertaken by the Medical Research Institute of New Zealand (MRINZ) shows that adults with asthma can safely simplify their treatment, reduce overall steroid exposure and improve asthma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback